Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing
Ptashkin, R. N.; Ewalt, M. D.; Jayakumaran, G.; Kiecka, I.; Bowman, A. S.; Yao, J.; Casanova, J.; Lin, Y.-T. D.; Petrova-Drus, K.; Mohanty, A. S.; Bacares, R.; Benhamida, J.; Rana, S.; Razumova, A.; Vanderbilt, C.; Remav, A. B.; Rijo, I.; Son-Garcia, J.; Bruijn, I. d.; Zhu, M.; Lachhander, S.; Wang, W.; Haque, M. S.; Seshan, V. E.; Wang, J.; Liu, Y.; Nafa, K.; Borsu, L.; Zhang, Y.; Aypar, U.; Suehnholz, S. P.; Chakravarty, D.; Park, J. H.; Abdel-Wahab, O.; Mato, A. R.; Xiao, W.; Roshal, M.; Yabe, M.; Batlevi, C. L.; Giralt, S.; Salles, G.; Rampal, R.; Tallman, M.; Stein, E. M.; Younes, A.; Lev
Show abstract
Genomic profiling of hematologic malignancies has augmented our understanding of variants that contribute to disease pathogenesis and supported development of prognostic models that inform disease management in the clinic. Tumor only sequencing assays are limited in their ability to identify definitive somatic variants, which can lead to ambiguity in clinical reporting and patient management. Here, we describe the MSK-IMPACT Heme cohort, a comprehensive data set of somatic alterations from paired tumor and normal DNA using a hybridization capture-based next generation sequencing platform. We highlight patterns of mutations, copy number alterations, and mutation signatures in a broad set of myeloid and lymphoid neoplasms. We also demonstrate the power of appropriate matching to make definitive somatic calls, including in patients who have undergone allogeneic stem cell transplant. We expect that this resource will further spur research into the pathobiology and clinical utility of clinical sequencing for patients with hematologic neoplasms.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Mapping AML heterogeneity – multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses 96%
- Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network 95%
- Combining LSD1 and JAK-STAT inhibition targets Down syndrome-associated myeloid leukemia at its core 94%
Similar papers in this journal
- Copy number signatures predict chromothripsis and associate with poor clinical outcomes in patients with newly diagnosed multiple myeloma 95%
- Accelerated single cell seeding in relapsed multiple myeloma 95%
- Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia 95%
Similar papers in this journal
- CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia 94%
- First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer 94%
- Stable colony stimulating factor 1 fusion protein treatment increases HSC pool and enhances their mobilisation in mice. 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.